You have 9 free searches left this month | for more free features.

Condition

Lymphoma, Large B-Cell, Diffuse (1)

Rheumatoid Arthritis (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Celgene (2)

Collaborator

Intervention

cc-292 (2)

cc-122 (1)

cc-223 (1)

placebo (1)

rituximab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

Spebrutinib

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (CC-122, CC-223, Rituximab)

Active, not recruiting

Lymphoma, Large B-Cell, Diffuse

CC-122
+3 more

Santa Barbara, California
+22 more

Jan 25, 2023

Rheumatoid Arthritis Trial in United States (CC-292, Placebo)

Completed

Rheumatoid Arthritis

CC-292
Placebo

Birmingham, Alabama
+26 more

Jul 27, 2017